Personalis, Inc.

PSNL

Personalis, Inc.

PSNL

Insider Sentiment (TTM):

Last Purchase:2025-12-22Last Sale:2026-06-29Shares Purchased (TTM):28,000Shares Sold (TTM):449,604

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:77,009,259Shares Outstanding:104,191,862Institutional Ownership Pct.:73.91%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	94	74	124	50	53	71	91	76	48	44	57	72
Short Term Investments	119	160	116	101	120	115	94	68	39	51	57	48
Prepaid Expense And Other Assets Current	8	5	6	5	5	5	4	5	4	5	4	6
Assets Current	245	258	268	174	193	206	203	170	113	120	147	148
Property Plant And Equipment Net	49	48	45	47	46	48	48	50	53	55	57	57
Operating Lease Right Of Use Asset	15	15	15	15	16	16	16	17	17	18	18	18
Other Assets Noncurrent	4	4	6	6	4	3	3	3	3	3	3	4
Assets	312	325	334	243	259	273	270	240	186	195	225	227
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	16	13	13	11	10	8	6	12	10	9	15	9
Liabilities Current	46	39	40	36	32	30	31	36	34	31	47	32
Operating Lease Liability Noncurrent	30	31	32	33	33	34	35	36	37	37	38	39
Other Liabilities Noncurrent	0	1	1	3	3	2	1	1	1	3	5	4
Liabilities	77	71	73	71	68	66	67	73	73	75	96	75
Stockholders Equity
Common Stock Value Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	928	916	892	779	777	773	753	700	607	602	598	594
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	-0	-0	0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-693	-661	-631	-607	-586	-566	-550	-534	-494	-482	-469	-442
Stockholders Equity	235	255	261	171	191	207	203	167	112	121	129	151
Liabilities And Stockholders Equity	312	325	334	243	259	273	270	240	186	195	225	227
Related Party	-	5	3	1	1	1	3	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	106	105	102	89	89	88	85	71	53	51	50	49
Shares Outstanding	106	105	102	89	89	88	85	71	53	51	50	49
Accounts Receivable Net Current	15	13	16	14	10	11	8	13	13	11	18	14
Contract With Customer Liability Current	3	4	2	1	2	2	3	3	4	4	3	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	90.32%	117.36%	96.66%	-	-	-	-	-	-	-	-	-
2025	15.75%	64.50%	62.25%	-13.30%	7.09%	71.63%	22.91%	-6.76%	16.49%	-19.60%	-25.47%	-29.57%
2024	-16.93%	-25.24%	120.45%	88.89%	81.25%	63.54%	-28.85%	5.20%	9.68%	-16.04%	-24.76%	16.75%
2023	-	-	-	-6.57%	-38.89%	-51.01%	52.65%	118.07%	42.26%	-2.74%	-11.64%	-4.11%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.28	6.61	6.76	4.82	6.09	6.91	6.52	4.68	3.31	3.84	3.11	4.56
Quick Ratio	5.12	6.48	6.62	4.69	5.95	6.74	6.40	4.55	3.20	3.68	3.01	4.39
Working Capital	198.67M	219.15M	228.32M	138.25M	161.62M	176.53M	171.89M	133.86M	78.97M	89.07M	99.51M	115.74M
Leverage & Debt
Debt to Equity	0.33	0.28	0.28	0.42	0.36	0.32	0.33	0.44	0.65	0.62	0.74	0.50
Interest Coverage TTM	-536.66	-457.69	-429.55	-573.78	-857.07	-1,490.73	-2,625.65	-2,180.21	-2,155.67	-1,374.88	-999.42	-797.63
Debt Ratio	0.25	0.22	0.22	0.29	0.26	0.24	0.25	0.30	0.39	0.38	0.42	0.33
Efficiency & Turnover
Asset Turnover TTM	0.24	0.22	0.23	0.29	0.36	0.37	0.34	0.38	0.37	0.32	0.28	0.26
Days Sales Outstanding TTM	65.63	67.88	63.79	73.55	51.97	47.53	55.80	56.61	52.57	72.48	85.37	70.53
Receivables Turnover TTM	5.56	5.38	5.72	4.96	7.02	7.68	6.54	6.45	6.94	5.04	4.28	5.17
Per Share Metrics
Diluted EPS TTM	-1.02	-0.92	-0.91	-0.83	-1.03	-0.96	-1.37	-1.50	-1.55	-1.83	-2.25	-2.32
Free Cash Flow Per Share TTM	-0.91	-0.86	-0.94	-0.57	-0.37	-0.53	-0.79	-0.90	-1.26	-1.35	-1.39	-1.57
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	12.69%	13.72%	22.65%	26.67%	31.45%	33.30%	31.70%	31.41%	27.76%	25.59%	24.78%	21.71%
Operating Profit Margin TTM	-164.07%	-158.91%	-126.43%	-117.08%	-89.64%	-78.28%	-80.68%	-84.73%	-113.13%	-133.51%	-149.61%	-167.38%
Net Profit Margin TTM	-153.84%	-148.11%	-116.69%	-106.92%	-113.70%	-98.10%	-96.06%	-104.52%	-101.78%	-124.90%	-147.38%	-159.91%
Growth Metrics
Net Revenue Growth (1Y)	-13.26%	-24.71%	-17.69%	-21.02%	0.36%	15.57%	15.15%	24.05%	19.20%	7.96%	12.97%	2.20%
Net Income Growth (1Y)	17.37%	13.66%	-0.02%	-19.20%	12.12%	-9.22%	-24.94%	-18.92%	-26.07%	-18.60%	-4.43%	10.09%
EPS Growth (1Y)	-1.46%	-4.59%	-33.62%	-44.39%	-33.64%	-47.40%	-38.97%	-35.33%	-32.74%	-24.93%	-9.33%	3.82%
Valuation Metrics
P/E TTM	-13.18	-6.95	-8.74	-7.83	-6.36	-3.65	-4.21	-3.59	-0.75	-0.82	-0.93	-0.52
P/B TTM	6.01	2.61	2.72	3.37	3.04	1.48	1.69	1.97	0.55	0.63	0.78	0.39
P/S TTM	20.28	10.29	10.20	8.37	7.23	3.58	4.05	3.75	0.77	1.02	1.38	0.84
Market Cap	1.41B	663.70M	710.35M	578.32M	580.67M	307.00M	342.47M	328.46M	61.30M	75.51M	101.17M	58.92M
Enterprise Value	1.32B	590.11M	586.11M	528.35M	527.30M	236.00M	251.06M	252.66M	13.55M	31.53M	44.18M	-13.27M
Calculated Values
Free Cash Flow TTM	-95.78M	-89.09M	-83.89M	-50.14M	-33.15M	-46.71M	-46.75M	-54.65M	-65.76M	-68.16M	-67.17M	-76.53M
Net Debt	-93.97M	-73.59M	-124.25M	-49.97M	-53.37M	-71.00M	-91.42M	-75.80M	-47.75M	-43.98M	-56.98M	-72.19M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-29Sale

Owner: Tachibana, Aaron

Title: CFO AND COO

Shares: 4,982

Price/Share: $14.00

Value: $69,748.00

Shares Owned: 198,833

Relationship: Officer

Ownership: Direct

2026-06-26Sale

Owner: Tachibana, Aaron

Title: CFO AND COO

Shares: 51,251

Price/Share: $13.18

Value: $675,488.18

Shares Owned: 198,833

Relationship: Officer

Ownership: Direct

2026-06-26Sale

Owner: Hall, Christopher M

Title: Chief Executive Officer

Shares: 100,000

Price/Share: $13.15

Value: $1,315,000.00

Shares Owned: 235,986

Relationship: Director,Officer

Ownership: Direct

2026-06-04Sale

Owner: Tachibana, Aaron

Title: CFO AND COO

Shares: 40,000

Price/Share: $12.01

Value: $480,400.00

Shares Owned: 198,833

Relationship: Officer

Ownership: Direct

2026-05-29Sale

Owner: Hall, Christopher M

Title: Chief Executive Officer

Shares: 80,091

Price/Share: $11.02

Value: $882,602.82

Shares Owned: 235,986

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-29	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	4,982	14.00	$69,748.00	198,833	4
2026-06-26	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	51,251	13.18	$675,488.18	198,833	4
2026-06-26	Hall, Christopher M	Director,Officer	Chief Executive Officer	Direct	Sale	100,000	13.15	$1,315,000.00	235,986	4
2026-06-04	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	40,000	12.01	$480,400.00	198,833	4
2026-05-29	Hall, Christopher M	Director,Officer	Chief Executive Officer	Direct	Sale	80,091	11.02	$882,602.82	235,986	4
2026-05-29	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	38,799	11.58	$449,292.42	198,833	4
2026-01-22	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	1,201	11.50	$13,811.50	164,458	4
2025-12-22	Tempus, Ai, Inc.	TenPercentOwner	-	Direct	Purchase	28,000	8.93	$250,040.00	13,039,067	4
2025-11-25	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	103,668	10.78	$1,117,541.04	164,458	4
2025-11-03	Hall, Christopher M	Director,Officer	PRESIDENT AND CEO	Direct	Sale	29,612	8.99	$266,211.88	148,486	4
2025-07-28	Chen, Richard	Officer	CHIEF MEDICAL OFFICER AND EVP	Direct	Sale	452	6.57	$2,969.64	124,505	4
2025-07-28	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	641	6.57	$4,211.37	164,458	4
2025-05-16	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	1,291	4.95	$6,390.45	165,099	4
2025-05-16	Moore, Stephen Michael	Officer	SVP and Chief Legal Officer	Direct	Sale	1,675	4.95	$8,291.25	64,200	4
2025-05-16	Chen, Richard	Officer	CHIEF MEDICAL OFFICER AND EVP	Direct	Sale	910	4.95	$4,504.50	124,957	4
2025-01-28	Chen, Richard	Officer	CHIEF MEDICAL OFFICER AND EVP	Direct	Sale	519	5.79	$3,005.01	123,367	4
2025-01-28	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	708	5.79	$4,099.32	166,390	4
2024-12-16	Moore, Stephen Michael	Officer	SVP and Chief Legal Officer	Direct	Sale	1,513	3.82	$5,779.66	65,875	4
2024-12-16	Chen, Richard	Officer	CHIEF MEDICAL OFFICER AND EVP	Direct	Sale	4,834	3.82	$18,465.88	123,886	4
2024-12-16	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	6,865	3.82	$26,224.30	167,098	4
2024-11-18	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	1,307	3.79	$4,953.53	173,963	4
2024-11-18	Chen, Richard	Officer	CHIEF MEDICAL OFFICER AND EVP	Direct	Sale	921	3.79	$3,490.59	128,720	4
2024-11-18	Moore, Stephen Michael	Officer	SVP and Chief Legal Officer	Direct	Sale	1,693	3.79	$6,416.47	67,388	4
2024-11-01	Hall, Christopher M	Director,Officer	PRESIDENT AND CEO	Direct	Sale	26,443	5.38	$142,263.34	178,098	4
2024-08-16	Tempus, Ai, Inc.	TenPercentOwner	-	Direct	Purchase	3,500,000	5.07	$17,745,000.00	12,718,800	4
2024-07-30	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	742	2.97	$2,203.74	175,270	4
2024-07-30	Chen, Richard	Officer	CHIEF MEDICAL OFFICER AND EVP	Direct	Sale	524	2.97	$1,556.28	127,227	4
2024-06-17	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	7,176	1.29	$9,257.04	176,012	4
2024-06-17	Moore, Stephen Michael	Officer	SVP and Chief Legal Officer	Direct	Sale	1,585	1.29	$2,044.65	69,081	4
2024-06-17	Chen, Richard	Officer	CHIEF MEDICAL OFFICER AND EVP	Direct	Sale	5,055	1.29	$6,520.95	127,751	4
2024-05-17	Chen, Richard	Officer	CHIEF MEDICAL OFFICER AND EVP	Direct	Sale	940	1.38	$1,297.20	132,806	4
2024-05-17	Moore, Stephen Michael	Officer	SVP and Chief Legal Officer	Direct	Sale	1,731	1.38	$2,388.78	70,666	4
2024-05-17	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	1,333	1.38	$1,839.54	183,188	4
2024-04-30	Moore, Stephen Michael	Officer	SVP and Chief Legal Officer	Direct	Sale	4,523	1.37	$6,196.51	72,397	4
2024-03-01	Myers, Woodrow A Jr	Director	-	Direct	Purchase	10,000	1.67	$16,700.00	26,116	4
2024-01-29	Tachibana, Aaron	Officer	CFO AND COO	Direct	Sale	716	1.37	$980.92	184,521	4
2024-01-29	Chen, Richard	Officer	CHIEF MEDICAL OFFICER AND EVP	Direct	Sale	526	1.37	$720.62	128,870	4
2023-12-15	Moore, Stephen Michael	Officer	General Counsel	Direct	Sale	1,476	1.47	$2,169.72	76,920	4
2023-12-15	Tachibana, Aaron	Officer	CFO and COO	Direct	Sale	6,747	1.47	$9,918.09	185,237	4
2023-12-15	Chen, Richard	Officer	Chief Medical Officer and EVP	Direct	Sale	4,708	1.47	$6,920.76	129,396	4
2023-11-16	Tachibana, Aaron	Officer	CFO and COO	Direct	Sale	1,344	1.04	$1,397.76	191,984	4
2023-11-16	Moore, Stephen Michael	Officer	General Counsel	Direct	Sale	1,722	1.04	$1,790.88	78,396	4
2023-11-16	Chen, Richard	Officer	Chief Medical Officer and EVP	Direct	Sale	940	1.04	$977.60	124,104	4
2023-11-01	Hall, Christopher M	Director,Officer	President and CEO	Direct	Sale	20,459	0.93	$19,026.87	204,541	4
2023-07-31	Chen, Richard	Officer	Chief Medical Officer and EVP	Direct	Sale	485	2.26	$1,096.10	125,044	4
2023-07-31	Tachibana, Aaron	Officer	CFO and COO	Direct	Sale	662	2.26	$1,496.12	193,328	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

73.91%

Inst. Shares: 77,009,259

Shares Outstanding: 104,191,862

2025-12-31

76.86%

Inst. Shares: 68,590,289

Shares Outstanding: 89,240,435

2025-09-30

69.57%

Inst. Shares: 61,712,341

Shares Outstanding: 88,699,131

2025-06-30

65.87%

Inst. Shares: 58,307,679

Shares Outstanding: 88,517,498

2025-03-31

61.73%

Inst. Shares: 53,991,506

Shares Outstanding: 87,463,885

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	77,009,259	104,191,862	73.91%
2025-12-31	68,590,289	89,240,435	76.86%
2025-09-30	61,712,341	88,699,131	69.57%
2025-06-30	58,307,679	88,517,498	65.87%
2025-03-31	53,991,506	87,463,885	61.73%
2024-12-31	50,814,258	59,251,013	85.76%
2024-09-30	28,471,280	61,051,350	46.63%
2024-06-30	20,061,206	52,394,678	38.29%
2024-03-31	19,542,979	50,678,586	38.56%
2023-12-31	20,106,497	48,175,201	41.74%
2023-09-30	23,584,325	48,694,324	48.43%
2023-06-30	24,967,145	47,669,513	52.38%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Personalis, Inc. (PSNL) — SEC Financial Statements & Analysis

Personalis, Inc. (PSNL) is a services-medical laboratories company, incorporated in DE. Personalis, Inc. trades on Nasdaq as: PSNL. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Personalis, Inc. reported a -13.26% year-over-year revenue growth, a Gross Profit Margin of 12.69% (TTM), a Debt-to-Equity ratio of 0.33x, a Price-to-Sales (P/S) ratio of 20.28x (TTM), a Price-to-Book (P/B) ratio of 6.01x (TTM), at a market cap of $1.41B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -13.26%
Gross Profit Margin TTM: 12.69%
Debt To Equity: 0.33x
P/S TTM: 20.28x
P/B TTM: 6.01x
Market Cap: $1.41B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Personalis, Inc. in?

Personalis, Inc. (PSNL) operates in the Services-Medical Laboratories industry.

What is PSNL's market cap?

Personalis, Inc. (PSNL) has a market capitalization of $1.41B as of 2026-06-30.

What exchange does PSNL trade on?

Personalis, Inc. (PSNL) trades on the Nasdaq.

Where is Personalis, Inc. incorporated?

Personalis, Inc. is incorporated in DE.

Personalis, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Personalis, Inc. (PSNL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Medical Laboratories

Wall Street's data.
Main Street's price.

Personalis, Inc. (PSNL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Medical Laboratories

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.